Investor Relations



We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in seven FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.

In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.




  • Jun 05

    Regeneron Announces Upcoming Investor Conference Presentations
  • Jun 01

    Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments


  • BMO 2020 Prescriptions for Success Healthcare Conference
    Jun 23
    10:00 AM EDT
    Jun 23, 2020 | 10:00 AM EDT

  • Credit Suisse Biotech Management & Board Call Series
    Jun 22
    8:00 AM EDT
    Jun 22, 2020 | 8:00 AM EDT

  • 2020 Annual Meeting of Shareholders
    Jun 12
    10:30 AM EDT
    Jun 12, 2020 | 10:30 AM EDT

  • Goldman Sachs 41st Annual Global Healthcare Conference
    Jun 9
    3:00 PM EDT
    Jun 9, 2020 | 3:00 PM EDT